HighVista Strategies’s CME Group CME Stock Holding History

HighVista Strategies’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,200	Closed	-$1.43M	–	155
2025 Q2	$1.43M	Buy	+5,200	New	+$1.41M	0.53%	71

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HighVista Strategies's CME Position: Q3 2025 in Review

HighVista Strategies sold out of CME Group (CME) in Q3 2025, closing a stake of 5,200 shares — an estimated $1.43M sold.

HighVista Strategies first reported a position in CME in Q2 2025 and held it in 1 quarter. The position peaked at $1.43M in Q2 2025. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

HighVista Strategies reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
HighVista Strategies sold 5,200 CME Group shares in Q3 2025, an estimated $1.43M.
HighVista Strategies first reported a position in CME Group in Q2 2025 and held it in 1 quarter.
HighVista Strategies's CME Group position peaked at $1.43M in Q2 2025.
1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on HighVista Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.